avandamet
smithkline beecham plc - rosiglitazone, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - avandamet is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients:who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea (see section 4.4).
avandia tablet
glaxosmithkline inc - rosiglitazone (rosiglitazone maleate) - tablet - 2mg - rosiglitazone (rosiglitazone maleate) 2mg - thiazolidinediones
avandia tablet
glaxosmithkline inc - rosiglitazone (rosiglitazone maleate) - tablet - 4mg - rosiglitazone (rosiglitazone maleate) 4mg - thiazolidinediones
avandia tablet
glaxosmithkline inc - rosiglitazone (rosiglitazone maleate) - tablet - 8mg - rosiglitazone (rosiglitazone maleate) 8mg - thiazolidinediones
avandia rosiglitazone 2mg (as maleate) tablet film coated blister pack
glaxosmithkline australia pty ltd - rosiglitazone maleate -
avandaryl 4-1mg f.c. tablets film-coated tablet
smiithkline beecham - glimepiride, rosiglitazone maleate - film-coated tablet - 4,1 mg
avandaryl 4-2mg f.c. tablets film-coated tablet
smiithkline beecham - glimepiride, rosiglitazone maleate - film-coated tablet - 4,2 mg
avandaryl 4-4mg f.c. tablets film-coated tablet
smiithkline beecham - glimepiride, rosiglitazone maleate - film-coated tablet - 4,4 mg
avandamet tablet
glaxosmithkline inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 1mg; 500mg - rosiglitazone (rosiglitazone maleate) 1mg; metformin hydrochloride 500mg - biguanides
avandamet tablet
glaxosmithkline inc - rosiglitazone (rosiglitazone maleate); metformin hydrochloride - tablet - 2mg; 500mg - rosiglitazone (rosiglitazone maleate) 2mg; metformin hydrochloride 500mg - biguanides